AbbVie : ABBV

All AbbVie Articles

584 Articles

Jon C. Ogg | Jul 2, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include…

Jon C. Ogg | Jun 2, 2014 at 8:55 AM EDT

Analyst Cancer and Biotech Stock Picks From ASCO

ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty…

Trey Thoelcke | May 22, 2014 at 8:20 AM EDT

Why You Buy Big Pharma If the Market Crashes

A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…

Jon C. Ogg | May 7, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, May 7, 2014. They include eBay, GNC,…

Paul Ausick | May 5, 2014 at 11:20 AM EDT

Why Target Shares Fell Rather Than Rose on CEO Firing

Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim…

Jon C. Ogg | Mar 27, 2014 at 9:15 AM EDT

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International is taking an activist investor role of its own. The health care company has announced that it is…

Trey Thoelcke | Mar 14, 2014 at 8:50 AM EDT

Jefferies’ Cheapest Health Care Stocks to Buy

In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Jon C. Ogg | Feb 8, 2014 at 8:30 AM EST

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

In Deutsche Bank's monthly quant view research piece, the firm looks for strategies that investors can implement to limit their…

Jon C. Ogg | Dec 30, 2013 at 11:30 AM EST

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List…

Jon C. Ogg | Dec 7, 2013 at 8:01 AM EST

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews…

Jon C. Ogg | Dec 3, 2013 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013.…

Jon C. Ogg | Oct 29, 2013 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

Jon OggWe are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new…

Jon C. Ogg | Oct 16, 2013 at 11:20 AM EDT

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

ThinkstockThe saying is that if there is a trading strategy, then there is an ETF strategy for that as well.…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

1 … 36 37 38 39

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Analyst Cancer and Biotech Stock Picks From ASCO

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies’ Cheapest Health Care Stocks to Buy

Merrill Lynch’s Top Health Care Stocks to Buy Now

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

The Surprising Reason Wednesday’s CPI Numbers Could be Good for Warsh and Bad for Social Security

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Analyst Cancer and Biotech Stock Picks From ASCO

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies’ Cheapest Health Care Stocks to Buy

Merrill Lynch’s Top Health Care Stocks to Buy Now

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

The Surprising Reason Wednesday’s CPI Numbers Could be Good for Warsh and Bad for Social Security

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip